Also, studies evaluating the association of progranulin and tau deposition in cognitive decline have shown that reduced levels of CSF progranulin in AD are associated with increased amounts of T-tau in these patients suggesting that progranulin prevents tau accumulation and in turn the risk of neurodegeneration [41]. Here, MAPT is linked to Alzheimer disease.